MedTrace Logo

Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

NCT01500499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood, tissue, and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies the role of biomarkers in disease progression in samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

gene rearrangement analysis

GENETIC

polymerase chain reaction

GENETIC

protein analysis

GENETIC

western blotting

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Julie D. Saba, MD, PhD · UCSF Benioff Children's Hospital Oakland

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500499 on ClinicalTrials.gov